background logo image

Episode 242

Q&A: Keto Safety After a Stent, During Pregnancy, and in Serious Mental Illness

Listen, Watch & Subscribe on:

Watch

Q&A: Keto Safety After a Stent, During Pregnancy, and in Serious Mental Illness

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director

Bret Scher, MD

Medical Director

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

About the host

Erica Gerard

Erica Gerard

Podcast producer

Erica Gerard

Podcast producer

Erica Gerard is an award-winning professional audio producer and narrative coach with lived experience of psychiatric recovery through ketogenic therapy. She specializes in helping people shape complex, sensitive experiences into clear, emotionally resonant stories. She spent 10 years writing and performing in the Los Angeles storytelling community and is a “The Moth” StorySlam Champion. She is the managing producer of Podkit Productions, a full service podcast production company specializing in mental health, wellness and personal development podcasts for purpose-driven organizations.
Learn more about Erica

Key Highlights

  • Dr. Scher explains that ketogenic diets are not absolutely contraindicated for people with atherosclerosis or stents, since he regularly treats such patients with ketogenic therapy as part of individualized cardiovascular care focused on improving lipid markers, blood pressure, and inflammation.
  • He reframes keto as a weight optimization diet rather than strictly a weight loss diet, noting that people can avoid losing weight by eating adequate fat and protein, snacking more, and incorporating calorie-dense foods like dairy and nuts.
  • Pregnancy and nursing are generally listed as contraindications for ketogenic diets due to case reports of ketoacidosis and increased caloric demands, but Dr. Scher says it may still be possible under close, experienced clinical supervision, never attempted independently.
  • He discusses Dr. Guido Frank’s 18-person pilot study of ketogenic diets in weight-restored anorexia patients, which found the diet safe, prevented weight loss, and produced significant improvements in eating disorder, depression, and anxiety symptoms, with theorized mechanisms involving changed brain energy metabolism and reduced neuroinflammation.
  • Addressing a claim that keto can “cure” schizophrenia, Dr. Scher clarifies it is not a cure but can induce symptom remission, emphasizes that mental illnesses like schizophrenia involve genetic predisposition modifiable by epigenetic and metabolic factors rather than being purely deterministic, and notes that ketogenic nutrition currently is not taught in medical schools despite its potential.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

Lipidologist Questions the New Keto and Liver Disease Study
Podcast

Lipidologist Questions the New Keto and Liver Disease Study

In this Metabolic Mind Bitesize episode, Dr. Bret Scher tackles a new study claiming ketogenic diets worsen fatty liver disease, a finding that appears to contradict prior research showing keto helps treat fatty liver. He breaks down why this retrospective cross-sectional study from China is deeply flawed, from never verifying ketosis to ignoring reverse causality and baseline differences, then contrasts it with a much stronger body of randomized controlled trial evidence showing the opposite conclusion.

Read more

Should You Add Intermittent Fasting to Your Keto Therapy?
Videos

Should You Add Intermittent Fasting to Your Keto Therapy?

Can intermittent fasting support ketosis and help treat serious mental illnesses like bipolar disorder, schizophrenia, depression, and anxiety? Transcript: Can intermittent fasting help with ketosis or help with…

Learn more

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More
Podcast

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More

Dr. Bret Scher and producer Erica tackle listener questions in this Metabolic Mailbag episode, covering whether keto helps or hurts AFib risk, concerns over the controversial KETO-CTA study's flawed initial data, and practical troubleshooting for someone experiencing low energy and brain fog despite strict adherence to keto. They wrap up with a stepwise approach for safely raising ketone levels when standard adjustments aren't working.

Learn more

Triglycerides Down, Plaque Unchanged: What This Trial Reveals
Podcast

Triglycerides Down, Plaque Unchanged: What This Trial Reveals

Dr. Bret Scher examines a new trial showing the drug olezarsen dramatically lowered triglycerides and ApoB, yet produced zero reduction in coronary artery plaque. He uses this as a case study for a broader point: lowering a lab number with a drug isn't the same as fixing the underlying metabolic dysfunction that caused it, drawing parallels to blood sugar, blood pressure, and weight management medications.

Learn more

Lipidologist Questions the New Keto and Liver Disease Study
Podcast

Lipidologist Questions the New Keto and Liver Disease Study

In this Metabolic Mind Bitesize episode, Dr. Bret Scher tackles a new study claiming ketogenic diets worsen fatty liver disease, a finding that appears to contradict prior research showing keto helps treat fatty liver. He breaks down why this retrospective cross-sectional study from China is deeply flawed, from never verifying ketosis to ignoring reverse causality and baseline differences, then contrasts it with a much stronger body of randomized controlled trial evidence showing the opposite conclusion.

Read more

Should You Add Intermittent Fasting to Your Keto Therapy?
Videos

Should You Add Intermittent Fasting to Your Keto Therapy?

Can intermittent fasting support ketosis and help treat serious mental illnesses like bipolar disorder, schizophrenia, depression, and anxiety? Transcript: Can intermittent fasting help with ketosis or help with…

Learn more

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More
Podcast

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More

Dr. Bret Scher and producer Erica tackle listener questions in this Metabolic Mailbag episode, covering whether keto helps or hurts AFib risk, concerns over the controversial KETO-CTA study's flawed initial data, and practical troubleshooting for someone experiencing low energy and brain fog despite strict adherence to keto. They wrap up with a stepwise approach for safely raising ketone levels when standard adjustments aren't working.

Learn more

Triglycerides Down, Plaque Unchanged: What This Trial Reveals
Podcast

Triglycerides Down, Plaque Unchanged: What This Trial Reveals

Dr. Bret Scher examines a new trial showing the drug olezarsen dramatically lowered triglycerides and ApoB, yet produced zero reduction in coronary artery plaque. He uses this as a case study for a broader point: lowering a lab number with a drug isn't the same as fixing the underlying metabolic dysfunction that caused it, drawing parallels to blood sugar, blood pressure, and weight management medications.

Learn more